First Hawaiian Bank Intercept Pharmaceuticals, Inc. Transaction History

First Hawaiian Bank

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q2 2019 Jul 15, 2019	SELL	$77.77 - $120.68 $2,177 - $3,379	-28 Closed	0 $0
Q3 2018 Oct 16, 2018	BUY	$88.49 - $127.55 $2,477 - $3,571	28 New	28 $4,000

1.04M

30K

5.9K

Ticker ICPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 41,127,400
Description
Intercept Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of therapeutics to treat progressive non-viral liver diseases in the United States, Europe, and Canada. The company markets Ocaliva, a farnesoid X receptor agonist used for the treatment of primary biliary cholangitis in combination wit...

Get notified when there are updates to the investment portfolio of First Hawaiian Bank, based on Form 13F filings with the SEC.

Stay updated on First Hawaiian Bank with notifications on news.